TLC C-53 liposomal prostaglandin-E1 to prevent platelet aggregation: Began placebo-controlled Phase II trial in 100 patients in combination with tPA, heparin, a

The Liposome Co. Inc. (LIPO), Princeton, N.J. Product: TLC C-53 liposomal prostaglandin-E1 to prevent platelet aggregation Indication: Heart attack Status: Began placebo-controlled Phase II trial in 1...